On the importance of accounting for competing risks in pediatric brain cancer: II. Regression modeling and sample size

International Journal of Radiation Oncology Biology Physics

Volumn 79, Issue 4, 2011, Pages 1139-1146

  Tai, Bee Choo ^a   Grundy, Richard ^b   MacHin, David ^c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Cause specific hazards; Competing risks; Subdistribution hazards

Indexed keywords

ADVERSE EFFECT; BENEFICIAL EFFECTS; BRAIN CANCER; BRAIN TUMORS; CAUSE-SPECIFIC HAZARDS; COMPETING RISKS; CONFIDENCE INTERVAL; CUMULATIVE INCIDENCE; EPENDYMOMA; HAZARD ANALYSIS; HAZARD FUNCTION; HAZARD RATIO; MAIN EVENT; REGRESSION MODELING; SAMPLE SIZE ESTIMATION; SAMPLE SIZES; STATISTICAL MODELING; STATISTICAL MODELS; SUBDISTRIBUTION HAZARDS;

DOSIMETRY; IRRADIATION; PESTICIDE EFFECTS; RADIOTHERAPY; TUMORS;

HAZARDS;

ACCOUNTING; ARTICLE; BRAIN CANCER; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; EPENDYMOMA; FEMALE; HISTOPATHOLOGY; HUMAN; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; SCHOOL CHILD; STATISTICAL MODEL;

BRAIN NEOPLASMS; CHILD; CLINICAL TRIALS, PHASE III AS TOPIC; CONFIDENCE INTERVALS; DISEASE PROGRESSION; EPENDYMOMA; HUMANS; MODELS, STATISTICAL; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; RISK ASSESSMENT; SAMPLE SIZE; TIME FACTORS;

EID: 79951960623     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.12.024     Document Type: Article

References (24)

1. R.G. Grundy, S.A. Wilne, and C.L. Weston Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: The UKCCSG/SIOP prospective study Lancet Oncol 8 2007 696 705 (Pubitemid 47189085)
2. R.G. Grundy, S.A. Wilne, and K. Robinson Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: Results of the first UKCCSG/SIOP CNS 9204 trial Eur J Cancer 46 2010 120 133
3. B.C. Tai, R.G. Grundy, and D. Machin On the importance of accounting for competing risks in pediatric cancer trials designed to delay or avoid radiotherapy: I. Basic concepts and first analyses Int J Radiat Oncol Biol Phys 76 2010 1493 1499
4. J. Wee, E.H. Tan, and B.C. Tai Randomized phase III trial of radiotherapy versus concurrent chemo-radiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety J Clin Oncol 23 2005 6730 6738 (Pubitemid 46190268)
5. J.P. Fine, and R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
6. J.D. Kalbfleisch, and R.L. Prentice The statistical analysis of failure time data 2nd ed. 2002 Wiley Hoboken, NJ
7. B.R. Logan, M.J. Zhang, and J.P. Klein Regression models for hazard rates versus cumulative incidence probabilities in hematopoietic cell transplantation data Biol Blood Marrow Transplant 12 2006 107 112 (Pubitemid 43034129)
8. D.R. Cox Regression models and life tables (with discussion) J Royal Stat Soc B 34 1972 187 220
9. M.J. Bradburn, T.G. Clark, and S.B. Love Survival analysis part II: Multivariate data analysis - An introduction to concepts and methods Br J Cancer 89 2003 431 436 (Pubitemid 37026422)
10. B.C. Tai, I. White, and V. Gebski Competing risks analysis of patients with osteosarcoma: A comparison of four different approaches Stat Med 20 2001 661 684 (Pubitemid 32177843)
11. H.T. Kim Cumulative incidence in competing risks data and competing risks regression analysis Clin Cancer Res 13 2007 559 565 (Pubitemid 46225362)
12. R. Gray A class of k-sample tests for comparing the cumulative incidence of a competing risk Ann Statist 16 1988 1141 1154
13. Gray RJ (2006). cmprsk: Subdistribution analysis of competing risks. R package version 2.1-7. http://www.r-project.org,http://biowww.dfci.harvard.edu/ ∼gray.
14. Stata survival analysis and epidemiological tables reference manual release 11 2009 StataCorp LP College Station, TX
15. D.A. Schoenfeld Sample-size formula for the proportional-hazards regression model Biometrics 39 1983 499 503 (Pubitemid 14267522)
16. A. Latouche, R. Porcher, and S. Chevret Sample size formula for proportional hazards modelling of competing risks Stat Med 23 2004 3263 3274 (Pubitemid 39462086)
17. M. Pintilie Dealing with competing risks: Testing covariates and calculating sample size Stat Med 21 2002 3317 3324 (Pubitemid 35314652)
18. A. Latouche, and R. Porcher Sample size calculations in the presence of competing risks Stat Med 26 2007 5370 5380 (Pubitemid 351193567)
19. M. Pintilie Competing risks: A practical perspective 2006 Wiley Hoboken, NJ
20. D. Machin, M.J. Campbell, S.B. Tan, and S.H. Tan Sample size tables for clinical studies 3rd ed. 2009 Wiley-Blackwell Chichester
21. J. Beyersmann, and M. Schumacher Misspecified regression model for the subdistribution hazard of a competing risk (Letter) Stat Med 26 2007 1649 1652 (Pubitemid 46403217)
22. A. Latouche, V. Boisson, S. Chevret, and R. Porcher Misspecified regression model for the subdistribution hazard of a competing risk Stat Med 26 2007 965 974 (Pubitemid 46291125)
23. J. Beyersmann, M. Dettenkofer, and H. Bertz A competing risks analysis of bloodstream infection after stem cell transplantation using subdistribution and cause-specific hazards Stat Med 26 2007 5360 5369 (Pubitemid 351193566)
24. P.R. Williamson, R. Kolamunnage-Dona, and C.T. Smith The influence of competing-risks setting on the choice of hypothesis test for treatment effect Biostatistics 8 2007 689 694 (Pubitemid 47511797)